Entity Common Stock, Shares Outstanding of MARINUS PHARMACEUTICALS, INC. from 12 Sep 2014 to 05 Nov 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
MARINUS PHARMACEUTICALS, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 12 Sep 2014 to 05 Nov 2024.
  • MARINUS PHARMACEUTICALS, INC. Entity Common Stock, Shares Outstanding for the quarter ending 05 Nov 2024 was 55,185,622, a 1.1% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

MARINUS PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 55,185,622 +612,041 +1.1% 05 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 55,084,038 +4,473,709 +8.8% 07 Aug 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 54,642,580 +4,977,463 +10% 29 Feb 2024 10-K 05 Mar 2024 2023 FY
Q3 2023 54,573,581 +17,376,937 +47% 03 Nov 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 50,610,329 +13,411,179 +36% 07 Aug 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 49,665,117 +12,661,698 +34% 03 Mar 2023 10-K 09 Mar 2023 2022 FY
Q3 2022 37,196,644 +430,289 +1.2% 31 Oct 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 37,199,150 +467,115 +1.3% 31 Jul 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 37,003,419 +424,959 +1.2% 18 Mar 2022 10-K 24 Mar 2022 2021 FY
Q3 2021 36,766,355 +6,172,290 +20% 31 Oct 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 36,732,035 -85,462,648 -70% 31 Jul 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 36,578,460 -50,132,575 -58% 08 Mar 2021 10-K 09 Mar 2021 2020 FY
Q3 2020 30,594,065 -23,275,232 -43% 05 Nov 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 122,194,683 +69,615,850 +132% 04 Aug 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 86,711,035 +34,192,022 +65% 12 Mar 2020 10-K 16 Mar 2020 2019 FY
Q3 2019 53,869,297 +13,344,284 +33% 05 Nov 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 52,578,833 +12,053,820 +30% 07 Aug 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 52,519,013 +11,998,308 +30% 11 Mar 2019 10-K 12 Mar 2019 2018 FY
Q3 2018 40,525,013 +94,817 +0.24% 26 Oct 2018 10-Q 29 Oct 2018 2018 Q3
Q2 2018 40,525,013 +14,449,522 +55% 01 Aug 2018 10-Q 03 Aug 2018 2018 Q2
Q1 2018 40,520,705 +18,978,493 +88% 05 Mar 2018 10-K 07 Mar 2018 2017 FY
Q3 2017 40,430,196 +20,724,701 +105% 30 Oct 2017 10-Q 31 Oct 2017 2017 Q3
Q2 2017 26,075,491 +6,566,271 +34% 27 Jul 2017 10-Q 01 Aug 2017 2017 Q2
Q1 2017 21,542,212 +2,032,992 +10% 10 Mar 2017 10-K 13 Mar 2017 2016 FY
Q3 2016 19,705,495 +5,370,643 +37% 07 Nov 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 19,509,220 +5,213,918 +36% 08 Aug 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 19,509,220 +5,309,554 +37% 07 Mar 2016 10-K 07 Mar 2016 2015 FY
Q3 2015 14,334,852 +422,697 +3% 29 Oct 2015 10-Q 29 Oct 2015 2015 Q3
Q2 2015 14,295,302 03 Aug 2015 10-Q 04 Aug 2015 2015 Q2
Q1 2015 14,199,666 12 Mar 2015 10-K 12 Mar 2015 2014 FY
Q3 2014 13,912,155 12 Sep 2014 10-Q/A 10 Oct 2014 2014 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.